Not the baseline insulin
The devices used in these trials ranged from visible red light (around 630 nm) to near-infrared light (800900 nm)
Serial blood samples were collected for PK analysis at pre-specified intervals up to 672 h after the final dose (pre-dose, 4, 6, 12, 24, 36, 48, 72, 120, 168, 336, and end-of-study at 672 h)
These lead to improving cardiac contractility and protecting cardiac structural integrity from damage
The many alternatives now enable healthcare practitioners to customise the formulation and delivery method according to specific patient preferences and requirements
Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: filling the gaps